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Chikungunya virus (CHIKV) is a mosquito-borne viral disease which is becoming a serious global 
public health problem. The principal vector in many parts of Africa is Aedes species. There are 
recent reports of CHIKV importation into Europe, Asia and America by travelers returning from 
west and central Africa. Yet, there is scanty information from the guinea savannah region of 
Nigeria. This study determined previous exposure to CHIKV in the urban population. It is a cross-
sectional study involving 89 participants enrolled from three hospitals in Ilorin, Kwara State. A 
qualitative Chikungunya Enzyme Linked Immunoassay kit was used to detect IgG antibodies. Data 
was analyzed using SPSS version 22. Statistically significant level was p≤0.05. Out of the study 
participants, 24.7% were previously exposed to CHIKV. Age group 31-40years had highest 
proportion while children under 10years had least IgG level. In this study, we found Chikungunya 
to be endemic in Ilorin Nigeria. There is need for sustained surveillance, to determine spatio-
temporal epidemiology of CHIKV. Efforts should be poised to strengthen vector control measures. 
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Chikungunya virus (CHIKV) is an RNA 
virus that belongs to Family: Togaviridae; 
genus: alphavirus (Strauss and Strauss, 
1994). Chikungunya epidemic was first 
observed from 1952-1953 in East Africa and 
isolation of the virus was carried out for the 
first time from serum of a febrile patient in 
the Tanganyika area (now Tanzania) in 1953 
(Lumsden, 1955; Robinson, 1955; Ross, 
1956). Between 1960s and 1980s, the virus 
was isolated repeatedly from numerous 
countries in central and southern Africa as 
well as in Senegal and Nigeria in western 
Africa (Halstead et al., 1969). It is a zoonotic 
virus that is maintained by interaction 
between non-human primates and Aedes 
mosquitoes in the forest cycle. The principal 
vector A. aegypti has spread throughout many 
parts of Nigeria (Onoja et al., 2016). It poses 
serious threat to human, as populations 
increase and expand geographically, 
facilitating contact with wildlife, disturbing 
their ecosystem for more agricultural activity 
to meet increased food demand (Bean et al., 
2013). Symptoms of CHIKV infection are 
nausea, myalgia, fever, headache, vomiting, 
arthralgia and rash (Powers et al., 2000) 
which are similar to clinical signs in people 
with dengue fever. Since CHIKV circulates 
in regions where dengue virus is equally 
endemic, many febrile infections are often 
misdiagnosed; hence incidence of 
Chikungunya is higher than what is reported 
especially in developing countries (Carey, 
1971). Reports of Chikungunya has been 
made in more than 40 countries around the 
world. Several outbreaks have been reported 
in China, Indian subcontinent, Central Africa 
and South-East Asia. CHIKV transmission 
has expanded to the Caribbean, Americas, 
countries in Europe and the Pacific where it 
was brought by infected travelers returning 
from endemic countries or regions (Weaver, 
2014; Nhan and Musso, 2015; Aubry et al., 
2015). First case of autochthonous infection 
in Italy occurred in 2007, with over 200 
people affected (Mavalankar et al., 2007; 
Watson, 2007; Liumbruno et al., 2008; 
Angelini et al., 2008; Vazeille et al., 2008). 
In 2008, the United States National Institute 
of Allergy and Infectious Diseases (NIAID) 
listed it as a Category C pathogen of priority 
(Staples et al., 2009). Epidemics of 
Chikungunya re-emerged and were 
documented in the Democratic Republic of 
Congo area of Kinshasa from 1999–2000 
(Pastorino et al., 2004), Indonesia from 
2001–2003 (Laras et al., 2005) and the Indian 
Ocean islands of Mayotte, Mauritius and the 
La Réunion from 2005–2006 (Saxena et al., 
2006). In West Africa, epidemics have been 
reported in Senegal (Diallo et al., 1999), 
Ivory Coast (Thonnon et al., 1999). Also, 
large outbreaks were reported in East Africa 
and Comoros from 2004–2005 (Powers and 
Logue, 2007). During the early dry season of 
1972, arbovirus surveillance was carried out 
in Saki, a rain forest region in Oyo State 
Nigeria and 24% Complement Fixing 
CHIKV antibody was reported (Fagbami, 
1978). Recently, 11% active Chikungunya 
was reported among people in the rainforest 
region (Ayorinde et al., 2015). However, 
there is scanty epidemiological information 
on CHIKV in the guinea Savannah region 
(north-central) of Nigeria. This study was 
designed to determine prevalence of past 
CHIKV infection among urban dwellers in 
Kwara State Nigeria. 
 






MATERIALS AND METHODS 
Study Design and Sample Collection 
This study is a cross-sectional study carried 
out among 89 participants randomly selected 
from the General Hospital, Civil Service 
Hospital and Cottage Hospital in Ilorin, 
Kwara State Nigeria. It is located in the 
guinea savannah vegetation zone, which 
breeds different species of mosquitoes 
(Okogun et al., 2005). Sample size (N) was 
determined using the formula N = Zα2pq/d2 
(Thiberville et al., 2013), where Zα = 
standard normal deviate set at 1.96, 
corresponding to 95% confidence interval 
(95% CI); p = proportion in the target 
population estimated to have a variable 
characteristic = 41.8% (0.418) from similar 
study in Nigeria (Ayorinde et al., 2015); q = 
1 - p = 58.2% (0.582); and d = degree of 
precision set at 0.05 (95% CI). Three 
milliliter of whole blood was aseptically 
collected by venipuncture into anticoagulant 
free tube from each consenting participant. 
This was allowed to stay at room temperature 
and centrifuged at 3000rpm for 5minutes in 
order to separate sera from clotted blood. 
Sera was subsequently collected into 
eppendorf tubes and shipped to the Arbovirus 
Research Laboratory in Department of 
Virology, College of Medicine, University of 
Ibadan, Nigeria where screening was done. 
Ethical approval MOH/KS/EU/777/275 was 
obtained for this study from Kwara State 
Ministry of Health and the study conformed 
to Ethics of Human subjects use in research 
following the Helsinki Declaration. Informed 
consent was obtained from adult participants, 
while parental assent was obtained from 
young persons under 18years of age. 
Inclusion criteria was visiting out-patients 
testing negative for malaria parasite 
examination and widal test. Infants, people 
who were positive for malaria, typhoid fever 
or HIV were excluded from the study.  
 
Serology  
Qualitative Competitive Chikungunya IgG 
ELISA kit was obtained from Cortez 
Diagnostics Inc. California, USA. The 
immunological assay detects human IgG 
antibodies by targeting CHIKV E2/E1 
proteins. Upon taken delivery of kit, ready-
to-use CHIKV antigen was immediately 
stored at -20oC while other reagents where 
held at +4oC until assay was to be carried out. 
Positive control, cut-off and negative control 
were assayed in duplicates. Samples and 
controls were diluted in ratio 1:100. Optical 
Density (OD) was visualized using single 
wavelength 450nm. Immune Serum Ratio 
(ISR) was calculated for each sample as mean 
ratio of OD450 value for test sample against 
mean OD450 value of Cut-Off control. ISR 
≥1.0 was considered positive while ISR <1.0 
OD was negative according to the 
manufacturers’ interpretation.    
 
Data Analysis   
Data were analyzed using IBM Statistical 
Package for Social Sciences, version 22. 
Pearson Chi square and Exact Fishers test 
was used to test for associations between 
variables. Descriptive data were presented in 












Out of 89 participants screened, 22 (24.7%) 
were positive. Out of this number, 16 
(25.8%) are females and 6 (22.2%) males. 
There was no significant difference in gender 
association between males and females (p = 
0.719). A 28 year old female had the highest 
Immune Serum Ratio (ISR) of 8.162, 
followed by a 31year old male with 8.140 
ISR. Age groups 31-40years had the highest 
proportion of people with CHIKV IgG. 
Those under 10years of age were least 
exposed (Figure I). There was no significant 
difference between ISR across age of 
participants (p = 0.267). There was no 
significant association observed between 
marital status and ISR (TABLE 1). 
Participants with tertiary education had 
higher proportion of CHIKV IgG while those 
in preschool were not previously exposed in 
this study (TABLE II). Civil servants and 
participants who engaged in business 
activities had equal proportion of exposure to 
CHIKV (TABLE III). There was no 
significant association between CHIKV IgG 
and blood groups (TABLE IV). Those who 
always used mosquito net and those who 
never used mosquito nets were equally 
exposed to CHIKV (TABLE V). There was 
no significant difference observed between 
those who used indoor spray and those who 
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TABLE I. Distribution of immune serum ratio according to marital status of participants 
      
          Immune Serum Ratio       
Marital status    <0.9999     >1.000       Total       p value   
Married 42 (47.2%)  15 (16.9%)   57 (64.0%)    
Single 24 (26.9%)   6 (6.7%) 30 (33.7%)        0.57   
Widowed   1 (1.12%)   1 (1.12%) 2 (2.25%)    
Total 67 (75.3%) 22 (24.7%) 89 (100.0%)     
 
 
TABLE II. Immune serum ratio based on educational status of participants 
      Immune Serum Ratio     
Education Status   <0.999     >1.000     Total       p value 
No Formal Education 11 (12.3%)   2 (2.2%) 13 (14.6%)  
Preschool   1 (1.1%)   0 (0.0%)   1 (1.1%)  
Primary Education   3 (3.4%)   2 (2.2%)   5 (5.6%)  
Secondary Education 29 (32.6%)     7 (7.9%) 36 (40.4%)  0.515 
Tertiary Education 23 (25.8%) 11 (12.3%) 34 (38.2%)  





TABLE III. Occupation of participants and distribution of immune serum ratio  
     
       Immune Serum Ratio     
Occupation   <0.999   >1.000 Total    p value 
Artisan   3 (3.4%)   3 (3.4%)   6 (6.7%)  
Business 29 (32.6%)   7 (7.9%) 36 (40.4%)  
Civil Servant   8 (8.9%)   7 (7.9%) 15 (16.9%) 0.151 
Student 22 (24.7%)   4 (4.5%) 26 (29.2%)  
Unemployed   5 (5.6%)   1 (1.1%)   6 (6.7%)  
Total 67 (75.3%) 22 (24.7%) 89 (100.0%)   
 






TABLE IV. Blood group and immune serum ratio of participants 
        Immune Serum Ratio     
Blood group    <0.999     >1.000    Total        p value 
AA 22 (24.7%) 10 (11.2%) 32 (35.9%)  
AS   8 (8.9%)   2 (2.2% 10 (11.2%)  
Not indicated 37 (41.6%) 10 (11.2%) 47 (52.8%) 0.562 
Total 67 (75.3%) 22 (24.7% 89 (100.0%)   
 
 
TABLE V. Distribution of immune serum ratio and some environmental determinants 
        Immune Serum Ratio     
Environmental determinants     <0.999     >1.000     Total   p-value 
Use of mosquito net     
No  49 (55.1%)   11 (12.4%)  60 (67.4%)  
Occasionally    0 (0.0%    1   (1.1%)   1 (1.1%) 0.046 
Always   18  (20.2%  10 (11.2%) 28 (31.5%)  
     
Use of indoor spray     
No  36 (40.4%)  10 (11.2%) 46 (51.7%)  
Occasionally    3 (3.4%)    3 (3.4%)   6 (6.7%) 0.319 
Always  28 (31.5%)    9 (10.1%) 37 (41.6%)  
     
Proximity to stagnant water     
No   61 (68.5%)  21 (23.6%) 82 (92.1%) 0.505 
Yes    6 (6.7%)    1 (1.1%)    7 (7.9%)  
     
Proximity to bush     
No  59 (66.3%)  20 (22.5%) 79 (88.8%)  
Yes    8 (8.9%)    2 (2.2%) 10 (11.2%) 0.713 
     











This observational survey highlights 
previous exposure to CHIKV infection in 
urban populations within the guinea 
Savannah region of Nigeria. Prevalence rate 
of 24.7% observed in this study is higher than 
4.1% reported in the arid north located in 
Sahel Savanah (Akinola et al., 2017) and 
lower than 31.4% reported in the rain forest 
southern region (Olajiga et al., 2017). In the 
arid part of Nigeria the climate is harsh and 
relatively high temperature does not favour 
preponderance of vectors hence the lower 
prevalence observed. Prevalence observed in 
guinea savannah area is slightly lower than in 
rain forest region because there are scanty 
trees, and reduced wildlife compared to rain 
forest region. The increased humidity and 
vegetation cover provides breeding ground 
for Aedes mosquitoes. Areas rich in wildlife 
such as rain forest region are thought to be 
hotspots for zoonotic diseases such as 
Chikungunya (Allen et al., 2017). However, 
risk of transmission in guinea Savannah 
region is higher than in arid northern parts of 
Nigeria hence it serves as an effective 
transmission zone for people on transit. 
Several studies that focused on predicting 
chikungunya disease persistence identified 
age (Scilte et al., 2013; Geradin et al., 2013; 
Essakjee et al., 2013) and sex (Essackjee et 
al., 2013) as major determinants of 
Chikungunya. But this present study found 
no significant association between gender 
and age (Figure I).  
There was no association between marital 
status and exposure to CHIKV (TABLE I). 
Since mosquitoes are not selective in their 
biting preferences, chances of infection are 
the same for married partners because they 
live in same house, most of the time. Children 
are likely to be exposed in a similar manner, 
if they are within the same house. This is 
because Aedes aegypti which is a major 
vector culprit is an indoor mosquito. Vector 
is infected once females take in viremic blood 
from infected individual. After successful 
extrinsic incubation period, vector is 
infectious and capable of transmitting 
CHIKV through bites of mosquitoes (Watts 
et al. 1987). Adult Aedes species like to rest 
on clothes and walls inside homes, where 
females take blood meals as they exclusively 
bite human hosts (Scott et al., 1993, 2000). 
Participants undergoing secondary and 
tertiary education had more exposure to 
CHIKV as shown in Table II. This is because 
they are mobile and likely to have acquired 
infection while commuting or trekking from 
their residences to school. It is a significant 
finding, which reinforces abundance of 
vectors. Ilorin climate is not arid, and 
therefore provides relative tropical 
environment for them to thrive. Businessmen 
and civil servants were equally exposed to 
CHIKV in this study (as shown in TABLE 
III). This is because vector bites everyone not 
minding their occupation. Although 
occupation does not matter with CHIKV 
exposure in this study, some occupations 
such as lumberjacks and farmers who 
frequently encroach into                         vector-
wildlife-ecosystems are predisposed to 
acquiring the infection. Although participants 
with blood group AA were more exposed 
(TABLE IV) there is no need to entertain 
fears of being more predisposed to CHIKV 
infection when compared to other blood 
groups. This is because CHIKV IgG mediates 






complete clearance of virus from 
cardiovascular system (Prince et al., 2015). 
Table V shows exposure of participants is 
irrespective of whether or not they are in 
close proximity to stagnant water, bush or if 
they use bed nets, whereas in other studies 
these environmental determinants have been 
shown to facilitate vector breeding (Dutta et 
al., 2011; Onyeneho, 2013; Tither, 2014). 
One reason that can be advanced for this is 
that the present study did not assay for active 
infection, which would have given a closer 
epidemiological link. Another study is 
needed to inform active CHIKV infection 
and determine incidence rates in Ilorin.  
CONCLUSION 
We have established in this present study that 
people in the guinea savannah are exposed to 
CHIKV. This study shows that competent 
vectors are prevalent in the region. This is 
worrisome because Ilorin is a transit point for 
people who traverse the north and southern 
parts of Nigeria. Further studies are needed to 
determine incidence rate of active 
Chikungunya infection in the guinea 
savannah region and to identify circulating 
clades, in order to know the extent of CHIKV 
transmission. This will inform strains to be 
incorporated in future vaccines for Africa. 
Additionally, this study will provide valuable 
information for chronic disease development, 
as patients with preceding Chikungunya 
disease might have higher chances of 
developing severe long-term disease 
associated with decreased long-term quality 
of life (Elsinga et al., 2018). Preventive 
measures and vector control efforts should be 
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